China Pharma Holdings (CPHI) Return on Invested Capital (2011 - 2018)

China Pharma Holdings' Return on Invested Capital history runs 8 years deep, the most recent figure standing at 0.01% for Q4 2018.

• Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.01% in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.01% (up 2.0% YoY) and the FY2025 annual result came in at 0.02%, up 1.0% from the prior year.
• Return on Invested Capital was 0.01% for Q4 2018 at China Pharma Holdings, up from 0.03% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2016 and bottomed at 0.12% in Q4 2014.
• A 5-year average of 0.03% and a median of 0.01% in 2015 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2014 — Return on Invested Capital decreased 9 bps — and 2015, when it gained 12 bps.
• China Pharma Holdings' Return on Invested Capital stood at 0.12% in 2014, then soared by 99 bps to 0.0% in 2015, then slumped by 587 bps to 0.01% in 2016, then slumped by 221 bps to 0.03% in 2017, then jumped by 57 bps to 0.01% in 2018.
• Business Quant data shows CPHI's Return on Invested Capital at 0.01% in Q4 2018, 0.03% in Q3 2018, and 0.03% in Q2 2018.